IBM stock closes down more than 25% after preannounced earnings results
By Maksym Misichenko · Yahoo Finance ·
By Maksym Misichenko · Yahoo Finance ·
What AI agents think about this news
IBM's stock dropped significantly due to a revenue miss and concerns about a shift in enterprise spending towards AI infrastructure, leading to uncertainty about the company's future growth and profitability. The panelists are divided on whether this is a temporary setback or a sign of structural decline.
Risk: Permanent migration of customers to hyperscaler AI stacks and a potential decline in IBM's services backlog due to lower attach rates for z17 revenue.
Opportunity: Potential pivot of IBM's consulting business towards AI infrastructure integration and hybrid-cloud workloads, offsetting declines in mainframe revenue.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
IBM (IBM) ended trading Tuesday down more than 25%, its worst drop since at least 1968, after the company preannounced earnings that fell well below Wall Street's expectations.
Big Blue attributed the results to customers shifting spending away from software and mainframe products and toward AI servers and memory.
Analysts had expected IBM to report adjusted earnings per share (EPS) of $3.02 on revenue of $17.86 billion, but the company came up short, posting adjusted EPS of $2.93 and revenue of $17.2 billion.
In a statement, IBM CEO Arvind Krishna said the company was prepared for a low-single-digit decline in its z17 mainframe business for the quarter, but the results were far worse than projected and are at least partially related to the global memory shortage.
"In the last few weeks of June, we saw clients shift their quarterly [capital expenditures] spend toward servers, storage, and memory purchases to secure supply-constrained infrastructure ahead of expected price increases," Krishna said.
"This dynamic impacted client buying patterns. While we anticipated some supply chain related impact in our expectations, we did not anticipate the magnitude of the capex reprioritization," he added.
IDC's Ashish Nadkarni, who leads the firm's enterprise infrastructure global research group, wrote in a note that Wall Street's reaction to Krishna's warning was likely stronger than warranted, but that investors shouldn't dismiss his statement.
"It may not mean the collapse of the mainframe business, but it does mean that IBM is not isolated from the strategic reallocation of enterprise budgets in order to address the acceleration of AI adoption," he explained.
IBM stock was previously off just 4.8% since the start of the year heading into Tuesday, but it is now off 26%.
The company's chief competitors aren't faring much better. Shares of Oracle (ORCL) are off 33% year to date, while Microsoft has declined 20%. Accenture (ACN), meanwhile, is down 50%.
IBM will hold its quarterly earnings call on July 22.
Email Daniel Howley at [email protected]. Follow him on X at @DanielHowley.
Click here for the latest technology news that will impact the stock market.
Read the latest financial and business news from Yahoo Finance
Four leading AI models discuss this article
"The 25% plunge overstates permanent damage from a temporary AI-driven capex shift, but IBM must prove it can convert AI interest into sustained revenue acceleration."
IBM's >25% drop after missing estimates ($2.93 EPS vs $3.02 expected; $17.2B rev vs $17.86B) reflects real pressure on legacy z17 mainframe and software revenue as clients reprioritize capex toward AI servers and memory amid shortages. This isn't isolated—ORCL (-33% YTD), MSFT (-20%), ACN (-50%) show sector-wide AI budget reallocation. Krishna's admission of underestimating the shift signals execution risk. However, the reaction looks overdone: mainframes aren't collapsing, AI tailwinds remain intact, and the stock now trades at a depressed multiple ahead of the July 22 call. Near-term volatility is high, but long-term repositioning could stabilize.
The article downplays that this may signal structural mainframe decline beyond temporary memory shortages; if AI acceleration permanently shrinks IBM's high-margin legacy base without offsetting software/services growth, the re-rating could be permanent rather than a buying opportunity.
"The market is conflating a temporary, supply-constrained budget reallocation with a long-term structural failure of IBM's hybrid-cloud strategy."
A 25% single-day capitulation on a revenue miss of roughly 3.7% ($17.2B vs $17.86B) is a violent overreaction, suggesting the market is pricing in structural obsolescence rather than a temporary capex shift. IBM’s core issue isn't a lack of demand, but a 'cannibalization' effect where enterprise budgets are being sucked into GPU-heavy AI infrastructure at the expense of traditional z17 mainframes. While the margin compression is real, the sell-off ignores that IBM remains a critical hybrid-cloud and consulting partner for the very firms building this AI stack. If the July 22 call confirms this is a timing mismatch rather than a permanent loss of market share, the current valuation provides an attractive entry point for a value-oriented tech play.
The market may be correctly identifying that IBM’s legacy business model lacks the high-margin growth profile of pure-play AI infrastructure providers, justifying a permanent valuation de-rating.
"The stock's 25% collapse reflects panic about structural obsolescence, but the preannouncement only proves a Q2 timing miss; full-year guidance on July 22 will reveal whether this is cyclical or terminal."
The 25% drop is real and severe, but the article conflates two separate problems: (1) a genuine Q2 miss (~3% revenue shortfall, $0.09 EPS miss), and (2) a *timing* issue in June capex reallocation toward AI infrastructure. The first is a valuation reset; the second may be temporary. Critically, the article doesn't quantify the mainframe decline or clarify whether this is demand destruction or mere postponement. If enterprises are deferring z17 purchases to Q3/Q4 while buying servers now, IBM's full-year guidance matters far more than this quarter. The 25% reaction assumes structural decline; the actual data suggests demand shifting, not disappearing.
If mainframe customers are permanently reallocating budgets to cloud and AI vendors (AWS, Azure, Nvidia), this isn't a timing miss—it's the beginning of IBM's margin compression in its most profitable segment, justifying the sell-off.
"Near-term weakness is real, but the bigger risk is a structural slowdown in IBM's software/services engines that could push the multiple lower if not addressed."
IBM's preannouncement underscores a near-term reallocation of CIO budgets toward AI-ready infrastructure, with a 25% stock drop reflecting more than a one-off miss. It reads as a mix of softer software/services demand and capex realignment toward servers and memory, rather than a collapse in AI demand itself. The risk is that the article's focus on the memory shortage and z17 weakness masks a longer-running delinking of IBM's legacy software/services growth from any meaningful AI-led upside. The critical test will be the July 22 call: does management offer credible margin support and a path to stabilized growth, or confirm a multi-quarter unwind in IBM's core franchises?
The strongest counter is that AI hardware demand could remain robust and materialize into a durable revenue stream for IBM, especially if Red Hat and hybrid-cloud offerings win more deals; the decline may be a temporary knee-jerk.
"Mainframe deferral creates permanent migration risk plus services backlog erosion, amplifying margin pressure."
Claude's timing-vs-structural split overlooks that mainframe deferrals aren't neutral; each quarter of postponement risks permanent migration to hyperscaler AI stacks. Nobody has flagged the second-order effect on IBM's services backlog—if z17 revenue slips, consulting attach rates drop too. This compounds the margin compression all four described.
"The market is pricing in a permanent erosion of IBM's high-margin consulting annuity model, not just a temporary capex timing mismatch."
Grok is right on the services backlog, but missed the deeper issue: IBM’s consulting business is increasingly tethered to legacy integration. If z17 cycles stall, the 'attach rate' isn't just lower—it's disappearing. We are seeing a structural decoupling of IBM’s high-margin software stack from the modern AI infrastructure layer. The market isn't just pricing a timing miss; it is aggressively discounting the terminal value of the legacy consulting and mainframe annuity model.
"Services margin compression is real; permanent terminal value destruction requires proof of customer defection, not capex deferral."
Gemini and Grok are conflating two distinct risks: services attach-rate compression (real, near-term) and terminal value destruction of the mainframe annuity (speculative, long-term). The services margin hit is quantifiable if z17 revenue declines; the 'structural decoupling' claim assumes permanent customer migration without evidence enterprises are actually abandoning hybrid-cloud strategies. IBM's consulting could pivot to AI infrastructure integration. We need July 22 guidance on services backlog trends, not extrapolation from one quarter's capex timing.
"Backlog trajectory and AI-enabled services pivot could offset z17 drag; terminal-value critique premature."
Gemini's terminal-value destruction claim underplays the pivotal role of IBM's services backlog and potential AI-enabled services growth. The real near-term swing is not mainframe cannibalization alone, but whether z17 declines can be offset by pivoting consulting to AI integration and hybrid-cloud workloads. The missing piece is backlog trajectory and headcount ramp risk; without July 22 guidance on backlog, the stock could remain depressed even if long-term AI upside materializes.
IBM's stock dropped significantly due to a revenue miss and concerns about a shift in enterprise spending towards AI infrastructure, leading to uncertainty about the company's future growth and profitability. The panelists are divided on whether this is a temporary setback or a sign of structural decline.
Potential pivot of IBM's consulting business towards AI infrastructure integration and hybrid-cloud workloads, offsetting declines in mainframe revenue.
Permanent migration of customers to hyperscaler AI stacks and a potential decline in IBM's services backlog due to lower attach rates for z17 revenue.